Emerald Advisers’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-313,477
| Closed | -$10.6M | – | 261 |
|
|
2022
Q3 | $10.6M | Buy |
313,477
+243,577
| +348% | +$8.24M | 0.55% | 78 |
|
|
2022
Q2 | $2.02M | Buy |
+69,900
| New | +$2.02M | 0.1% | 124 |
|
|
2018
Q1 | – | Sell |
-552,942
| Closed | -$22M | – | 266 |
|
|
2017
Q4 | $22M | Sell |
552,942
-52,978
| -9% | -$2.11M | 0.85% | 43 |
|
|
2017
Q3 | $24.2M | Buy |
605,920
+107,690
| +22% | +$4.31M | 0.99% | 36 |
|
|
2017
Q2 | $21.5M | Buy |
+498,230
| New | +$21.5M | 0.9% | 51 |
|